Development and external validation of a plasma metabolomic signature for predicting 3-year all-cause mortality in older adults with CAD
Authors:
- Jianhua GuJGJianhua Gu
- Luyao GaoLGLuyao Gao
- Jiqing LiJLJiqing Li
- Shuo WuSWShuo Wu
- Yuguo ChenYCYuguo Chen
- 7 February 2026
- journal article
- research article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 36 (6) , 104604
Abstract
No abstract availableKeywords
Funding Information
- Taishan Scholar Foundation of Shandong Province (tsqn202306356)
- Natural Science Foundation of Shandong Province (ZR2023QH381)
- National Natural Science Foundation of China (82402585)
- China Postdoctoral Science Foundation (2024M751847)
This publication has 35 references indexed in Scilit:
- Cardiovascular Risk Prediction in Older AdultsCurrent Atherosclerosis Reports, 2025
- Role of the microbiota–gut–heart axis between bile acids and cardiovascular diseaseBiomedicine & Pharmacotherapy, 2024
- Clinical Significance of Biological Age in Patients Undergoing Percutaneous Coronary InterventionMayo Clinic Proceedings, 2023
- VSOLassoBag: a variable-selection oriented LASSO bagging algorithm for biomarker discovery in omic-based translational researchJournal of Genetics and Genomics, 2023
- Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseasesActa Pharmaceutica Sinica B, 2021
- Fasting serum total bile acid level is associated with coronary artery disease, myocardial infarction and severity of coronary lesionsAtherosclerosis, 2020
- Coronary Artery Disease in Patients ≥80 Years of AgeJACC, 2018
- Comprehensive Metabolomic Characterization of Coronary Artery DiseasesJACC, 2016
- Management of Stable Angina – Current Guidelines: A Critical AppraisalCardiovascular Drugs and Therapy, 2016
- Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in WomenJAMA, 2007